Loading...
 

IMCA-CAT is a synchrotron-based structural biology research facility

optimized for high-throughput macromolecular crystallography

serving the pharmaceutical drug discovery community.

Image
The IMCA-CAT insertion device synchrotron beamline, designed with state-of-the-art equipment, is ideally suited for proprietary drug discovery research.


Image
Discovery and lead optimization phases of drug development are significantly accelerated at IMCA-CAT with high quality, ultra fast data acquisition for pharmaceutical structural biology.


Image
Each year, more than 15,000 structures are solved from data collected at the IMCA-CAT beamline.

LEARN MORE